Category: Endoscopic / ArthroscopicSyndicate content

Endoscopic / Arthroscopic

Medrobotics taps backers for $20m

October 21, 2014 by Alexander Soule

Medrobotics closes $20 million in new funding as it gear up to commercialize its robot-assisted flexible endoscope in Europe.

Medrobotics taps markets for $20m

Medrobotics said it closed on $20 million in new funding in a preferred stock sale to prior backers as plans to expand its commercial footprint in Europe.

Raynham, Mass.-based Medrobotics also said that it's "met all applicable FDA requirements" to distribute its Flex Retractor in the U.S.

Johnson & Johnson recalls power morcellators over cancer risk

July 31, 2014 by Brad Perriello

Johnson & Johnson voluntarily recalls power morcellators used in fibroid surgeries on the risk that they may unintentionally spread cancer.

Johnson & Johnson recalls power morcellators over cancer risk

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Steris, Medtrica win legal fees in Cygnus Medical patent spat

July 15, 2014 by Brad Perriello

A federal judge agrees to award legal fees to Steris and Medtrica in their patent infringement win over Cygnus Medical, after a U.S. Supreme court decision reboots the rules on awarding legal costs.

Steris, Medtrica win legal fees in Cygnus Medical patent spat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cantel Medical to pay $27M for endoscope reprocessor PuriCore

June 6, 2014 by Brad Perriello

Cantel Medical says it's agreed to pay nearly $27 million for British endoscope reprocessor PuriCore.

Cantel Medical to pay $27M for endoscope reprocessor PuriCore

Cantel Medical (NYSE:CMN) said it agreed to put up $26.9 million in cash to acquire PuriCore International, a British endoscope reprocessing company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA downgrades Given Imaging's PillCam

May 16, 2014 by Arezu Sarvestani

FDA medical device regulators put a lower-risk label on Covidien subsidiary Given Imaging's PillCam ingestible endoscopic camera.

FDA downgrades Given Imaging's PillCam

Covidien (NYSE:COV) subsidiary Given Imaging landed a victory with FDA medical device regulators who agreed to downgrade the PillCam capsule endoscope to a lower-risk classification.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien lands FDA OK for camera-equipped feeding tube

April 18, 2014 by Arezu Sarvestani

Covidien touts FDA clearance for its novel camera-equipped Kangaroo feeding tube designed to provide visualization for an otherwise blind procedure.

Covidien lands FDA OK for camera-equipped feeding tube

Medtech titan Covidien (NYSE:COV) received FDA clearance for its visual Kangaroo feeding tube, equipped with an endoscopic camera that allows physicians to see into the procedure in a new way.

Report: Covidien pays $100M for New Wave Surgical

April 11, 2014 by Brad Perriello

Covidien reportedly agreed to a $100 million buyout of New Wave Surgical and its D-Help device, designed to keep endoscope lenses clear during surgeries.

Report: Covidien pays $100M for New Wave Surgical

Covidien (NYSE:COV) reportedly paid $100 million to acquire New Wave Surgical and its medical device for keeping endoscope lenses clear during surgeries.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp